Tingxiao Gao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tingxiao Gao has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Alain Bergeron
Axe oncologie, Centre de recherche du CHU de Québec-Université Laval, Québec, Canada
1 shared publication - Alejandro Berlin
Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
1 shared publication Bernard Têtu
Research Centre of CHU de Québec-Université Laval, Québec City, Québec, Canada
1 shared publication- Chuan He
Department of Chemistry, University of Chicago, Chicago, USA
1 shared publication Deisha Paliwal
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
1 shared publication- Eugenia Flores-Figueroa
Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 6 June 2025
- Published by Springer Nature in Nature Methods
- Vol. 22 (7) , 1505-1519
CellNEST reveals cell–cell relay networks using attention mechanisms on spatial transcriptomics
Dysregulation of communication between cells mediates complex diseases such as cancer and diabetes; however, detecting cell–cell communication at scale remains one of the greatest challenges in transcriptomics. Most current single-cell RNA sequencing and spatial transcriptomics computational approaches exhibit high false-positive rates, do not detect signals between individual cells and only identify single ligand–receptor communication. To overcome these challenges, we developed Cell Neural Networks on Spatial Transcriptomics (CellNEST) to decipher patterns of communication. Our model introduces a new type of relay-network communication detection that identifies putative ligand–receptor–ligand–receptor communication. CellNEST detects T cell homing signals in human lymph nodes, identifies aggressive cancer communication in lung adenocarcinoma and colorectal cancer, and predicts new patterns of communication that may act as relay networks in pancreatic cancer. Along with CellNEST, we provide a web-based, interactive visualization method to explore in situ communication. CellNEST is available at https://github.com/schwartzlab-methods/CellNEST.
- 6 June 2025
- Published by Springer Nature in Nature Methods
- Vol. 22 (7) , 1505-1519
Top Cited PapersOpen AccessCellNEST reveals cell–cell relay networks using attention mechanisms on spatial transcriptomics
Dysregulation of communication between cells mediates complex diseases such as cancer and diabetes; however, detecting cell–cell communication at scale remains one of the greatest challenges in transcriptomics. Most current single-cell RNA sequencing and spatial transcriptomics computational approaches exhibit high false-positive rates, do not detect signals between individual cells and only identify single ligand–receptor communication. To overcome these challenges, we developed Cell Neural Networks on Spatial Transcriptomics (CellNEST) to decipher patterns of communication. Our model introduces a new type of relay-network communication detection that identifies putative ligand–receptor–ligand–receptor communication. CellNEST detects T cell homing signals in human lymph nodes, identifies aggressive cancer communication in lung adenocarcinoma and colorectal cancer, and predicts new patterns of communication that may act as relay networks in pancreatic cancer. Along with CellNEST, we provide a web-based, interactive visualization method to explore in situ communication. CellNEST is available at https://github.com/schwartzlab-methods/CellNEST.
- Open Access
- 24 March 2025
- Published by Springer Nature in Nature Genetics
- Vol. 57 (4) , 934-948
The landscape of N6-methyladenosine in localized primary prostate cancer
N6-methyladenosine (m6A), the most abundant internal RNA modification in humans, regulates most aspects of RNA processing. Prostate cancer is characterized by widespread transcriptomic dysregulation; therefore, we characterized the m6A landscape of 162 localized prostate tumors with matched DNA, RNA and protein profiling. m6A abundance varied dramatically across tumors, with global patterns emerging via complex germline–somatic cooperative regulation. Individual germline polymorphisms regulated m6A abundance, cooperating with somatic mutation of cancer driver genes and m6A regulators. The resulting complex patterns were associated with prognostic clinical features and established the biomarker potential of global and locus-specific m6A patterns. Tumor hypoxia dysregulates m6A profiles, bridging prior genomic and proteomic observations. Specific m6A sites, such as those in VCAN, drive disease aggression, associating with poor outcomes, tumor growth and metastasis. m6A dysregulation is thus associated with key events in the natural history of prostate cancer: germline risk, microenvironmental dysregulation, somatic mutation and metastasis.
- 24 March 2025
- Published by Springer Nature in Nature Genetics
- Vol. 57 (4) , 934-948
Open AccessThe landscape of N6-methyladenosine in localized primary prostate cancer
N6-methyladenosine (m6A), the most abundant internal RNA modification in humans, regulates most aspects of RNA processing. Prostate cancer is characterized by widespread transcriptomic dysregulation; therefore, we characterized the m6A landscape of 162 localized prostate tumors with matched DNA, RNA and protein profiling. m6A abundance varied dramatically across tumors, with global patterns emerging via complex germline–somatic cooperative regulation. Individual germline polymorphisms regulated m6A abundance, cooperating with somatic mutation of cancer driver genes and m6A regulators. The resulting complex patterns were associated with prognostic clinical features and established the biomarker potential of global and locus-specific m6A patterns. Tumor hypoxia dysregulates m6A profiles, bridging prior genomic and proteomic observations. Specific m6A sites, such as those in VCAN, drive disease aggression, associating with poor outcomes, tumor growth and metastasis. m6A dysregulation is thus associated with key events in the natural history of prostate cancer: germline risk, microenvironmental dysregulation, somatic mutation and metastasis.
- Open Access
- 15 September 2023
- Published by BMJ in BMJ Open Ophthalmology
- Vol. 8 (1) , e001330
Bibliometric analysis of the uveitis literature and research trends over the past two decades
Objective This study aimed to examine the publication patterns and present a current view of the field of uveitis using a bibliometric analysis. Design Bibliometric analysis. Methods and analysis A comprehensive search of three databases including MEDLINE, EMBASE and Cochrane was conducted from 1 January 2000 to 31 December 2022. Search results from all three databases were subjected to analysis by Bibliometrix, an R programme that analyses large literature dataset with statistical and mathematical models. Visualisation of collaboration networks and relevance between countries was presented with VOSviewer. Results A total of 26 296 articles were included in the analysis. The field of uveitis has undergone a significant exponential growth since 2000, with an average growth rate of 4.14%. The most substantial annual growth was between the years 2021 and 2022 (36%). According to the corresponding author’s countries, the three most productive countries were Turkey (3288, 12.6%), the USA (3136, 12%) and Japan (1981, 7.6%). The USA (243, 31.4%), England (117, 15%) and Germany (62, 8%) are the top three countries that contributed to clinical trials. The average international collaboration of all countries was 2.5%. Conclusions Uveitis literature has undergone significant growth in the past two decades. The demographic factors of publishing countries lead to their various productivity and types of these uveitis studies, which is closely associated with the countries’ scientific research resources and patient populations.
- 15 September 2023
- Published by BMJ in BMJ Open Ophthalmology
- Vol. 8 (1) , e001330
Open AccessBibliometric analysis of the uveitis literature and research trends over the past two decades
Objective This study aimed to examine the publication patterns and present a current view of the field of uveitis using a bibliometric analysis. Design Bibliometric analysis. Methods and analysis A comprehensive search of three databases including MEDLINE, EMBASE and Cochrane was conducted from 1 January 2000 to 31 December 2022. Search results from all three databases were subjected to analysis by Bibliometrix, an R programme that analyses large literature dataset with statistical and mathematical models. Visualisation of collaboration networks and relevance between countries was presented with VOSviewer. Results A total of 26 296 articles were included in the analysis. The field of uveitis has undergone a significant exponential growth since 2000, with an average growth rate of 4.14%. The most substantial annual growth was between the years 2021 and 2022 (36%). According to the corresponding author’s countries, the three most productive countries were Turkey (3288, 12.6%), the USA (3136, 12%) and Japan (1981, 7.6%). The USA (243, 31.4%), England (117, 15%) and Germany (62, 8%) are the top three countries that contributed to clinical trials. The average international collaboration of all countries was 2.5%. Conclusions Uveitis literature has undergone significant growth in the past two decades. The demographic factors of publishing countries lead to their various productivity and types of these uveitis studies, which is closely associated with the countries’ scientific research resources and patient populations.